Carbon Monoxide Poisoning Effectively Treated with High-flow Nasal Cannula

Area of Science:

• Emergency Medicine
• Toxicology
• Respiratory Care

Background:

• Carbon monoxide (CO) poisoning is a common yet serious condition requiring prompt treatment.
• Oxygen therapy, typically via a non-rebreather mask (NRB), is the standard of care.
• High-flow nasal cannula (HFNC) has emerged as a viable alternative to NRB in various clinical scenarios.

Observation:

• A case study involving a 29-year-old male with acute carbon monoxide poisoning is presented.
• The patient presented with a significantly elevated carboxyhemoglobin (COHb) level of 29.8%.
• High-flow nasal cannula (HFNC) was utilized as the primary treatment modality.

Findings:

• The administration of oxygen via HFNC resulted in a substantial decrease in COHb levels.
• COHb levels dropped from 29.8% to 5.4% within 230 minutes of HFNC treatment.
• This demonstrates the efficacy of HFNC in accelerating the clearance of carbon monoxide from the body.

Implications:

• High-flow nasal cannula (HFNC) presents a promising and potentially advantageous alternative to non-rebreather masks (NRB) for treating acute carbon monoxide poisoning.
• The theoretical benefits of HFNC, such as improved patient comfort and consistent oxygen delivery, warrant further investigation.
• This case report suggests that HFNC should be considered in the clinical management of carbon monoxide poisoning.